HFECX
Price
$55.08
Change
-$0.01 (-0.02%)
Updated
Aug 15 closing price
Net Assets
651.45M
VEURX
Price
$42.36
Change
+$0.07 (+0.17%)
Updated
Aug 15 closing price
Net Assets
32.87B
Interact to see
Advertisement

HFECX vs VEURX

Header iconHFECX vs VEURX Comparison
Open Charts HFECX vs VEURXBanner chart's image
Janus Henderson European Focus C
Price$55.08
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets651.45M
Vanguard European Stock Investor
Price$42.36
Change+$0.07 (+0.17%)
VolumeN/A
Net Assets32.87B
HFECX vs VEURX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HFECX vs. VEURX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFECX is a Buy and VEURX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 32.9B vs. HFECX (651M). VEURX pays higher dividends than HFECX: VEURX (2.88) vs HFECX (0.38). HFECX was incepted earlier than VEURX: HFECX (24 years) vs VEURX (35 years). HFECX (2.25) is less costly to investors than VEURX (0.24). HFECX is a more actively managed with annual turnover of: 168.00 vs. VEURX (3.00). VEURX has a lower initial minimum investment than HFECX: VEURX (0) vs HFECX (2500). HFECX annual gain was more profitable for investors over the last year : 21.25 vs. VEURX (15.41). HFECX return over 5 years is better than : 75.30 vs. VEURX (46.69).
HFECXVEURXHFECX / VEURX
Total Expense Ratio2.060.24858%
Annual Report Gross Expense Ratio2.250.24938%
Fund Existence24 years35 years-
Gain YTD29.83723.994124%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets651M32.9B2%
Annual Yield % from dividends0.382.8813%
Returns for 1 year21.2515.41138%
Returns for 3 years53.8641.79129%
Returns for 5 years75.3046.69161%
Returns for 10 years72.2849.26147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AREN6.870.17
+2.54%
Arena Group Holdings (The)
MAIA1.580.02
+1.28%
MAIA Biotechnology
VRDN18.540.10
+0.54%
Viridian Therapeutics
ALDFU10.50N/A
N/A
Aldel Financial II Inc
GGAL48.26-1.18
-2.39%
Grupo Financiero Galicia SA